Advanced Filters
noise

San Donato Milanese (MI), Italy Clinical Trials

A listing of San Donato Milanese (MI), Italy clinical trials actively recruiting patients volunteers.

Found 928 clinical trials
P Paolo G. Casali, MD

Observational Study on Endometrial Stromal Tumors

Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)

18 - 80 years of age Female Phase N/A

68Ga-DOTATOC PET for the Evaluation of Gastroenteropancreatic Neuroendocrine Tumours

Gastroenteropancreatic neuroendocrine tumours (GEP-NETs) are a heterogeneous group of neoplasms that arise from the endocrine cells of the gastroenteropancreatic tract. The diagnostic work-up of these tumours include Computed Tomography (CT), Endoscopic Ultrasound (EUS), Magnetic Resonance Imaging (MRI). The majority of these tumours express somatostatin receptors on their surface. For this …

18 years of age All Phase N/A
C Celeste Cagnazzo, PhD

Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas

Bone and soft tissue sarcomas represent about 7-12% of all pediatric cancer and are a heterogeneous group of tumors arising in connective tissues embryologically derived from the mesenchyme. For some of these tumors relapse and mortality rates are still significantly high. Therefore, further studies are needed to better understand pathogenetic …

- 24 years of age All Phase N/A

Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS

The high incidence of barotrauma in patients with COVID-19-related acute respiratory distress syndrome (ARDS) (16.1%, with a mortality rate >60%) provides rationale for considering COVID-19 ARDS a paradigm for lung frailty. The investigators recently discovered that the Macklin effect is an impressive radiological predictor of barotrauma in COVID-19 ARDS. Since …

18 years of age All Phase N/A

A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)

This is a 10-year multi-center, global, observational study to further characterize the safety profile of pegvaliase, including hypersensitivity reactions, long-term safety and tolerability, and the effectiveness of the additional risk minimization measures (aRMMs) (European Union (EU) only) in subjects receiving pegvaliase for the treatment of PKU. Subjects for whom a …

years of age All Phase N/A
C Camilla Torlasco, M.D.

CMR Assessment of Cardiac Microvascular Dysfunction in Patients With HFpEF

Heart failure with preserved ejection fraction (HFpEF) causes hospitalizations, premature mortality and high health care costs. This is also due to poor understanding of HFpEF pathogenesis and, thus, lack of specific therapies. Prompted by the recent demonstration that HFpEF clusters different clinical phenotypes, the investigators propose that these phenogroups are …

18 years of age All Phase N/A
V Valentina Morelli

Residual Adrenal Function in Addison's Disease

The main aim of this study is to assess the role of 11-deoxycortisol as surrogate marker of Residual adrenal function. 11-deoxycortisol levels will be assessed in all recruited patients

18 - 80 years of age All Phase N/A
M Maria Teresa Seccia, MD, PhD

Phenotypisation of Sleep Pattern in Hypertensive Patients With Non Dipper Pattern

High blood pressure is the most common modifiable risk factor for cardiovascular diseases (CV). The large interindividual variability in clinical expression of the disease and response to treatment, however, makes the management of the hypertensive patient complex.Therefore, identifying phenotypes of hypertensive patients associated with a specific CV outcome or who …

18 years of age All Phase N/A
S Sara SP Poletti, phd

Immune Activation, Neural Plasticity and Depression

Major depressive disorder (MDD) is a chronic, recurring and potentially life-threatening illness that affects up to 10% of the population across the globe.Increasing evidence indicates a clear link between immune dysfunction and MDD.Moreover, an activation of inflammatory pathways is associated to a lack of clinical response to antidepressants. Thus, the …

18 - 65 years of age All Phase N/A
J Jonica Campolo, MSc

Vascular Senescence and Atherosclerotic Plaque Vulnerability

Chronological aging significantly contributes to structural and functional alterations in the vasculature, making it a major risk factor for atherosclerotic disease and its acute thrombotic events. DNA damage, including telomeric, non-telomeric, and mitochondrial damage, is recognized as a key initiator of vascular aging and atherogenesis. There is abundant evidence indicating …

18 - 75 years of age All Phase N/A

Simplify language using AI